Medical Health & Life Science Research News

Research delivers insight into the Middle-East and Africa's diabetic retinopathy market forecasts 2016–2021

Research delivers insight into the Middle-East and Africa's diabetic retinopathy market forecasts 2016–2021

Middle-East and Africa Diabetic Retinopathy Market by Type of Treatment (Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy), By Indication

- Advertising -

The Middle-East and Africa Diabetic Retinopathy Market has been estimated at USD 0.61 billion in 2016 and is projected to reach USD 0.85 billion by 2021, at a CAGR of 6.86% during the forecast period from 2016 to 2021.

View Full Report @ www.marketdataforecast.com/market-…pathy-market-941/

Diabetic retinopathy, the most common diabetic eye disease, occurs when blood vessels in the retina change. Sometimes these vessels close off completely or even swell and leak fluid.

In other cases, abnormal new blood vessels grow on the surface of the retina.

- Advertising -

Request Sample @ www.marketdataforecast.com/market-…41/request-sample

Remarkable rise in incidence of diabetes in Middle East and Africa make the region fastest developing geographical market during the forecast period. Other drivers of diabetic retinopathy market in Middle East and Africa markets are increasing focus of market players to advance their foothold in Middle East market, rapid development of healthcare infrastructure, and growing government and non-government initiatives for emerging consciousness about diabetes management in the general population.

Inquire Report @ www.marketdataforecast.com/market-…arket-941/inquire

The Middle-East and Africa Diabetic Retinopathy Market has been segmented on the basis of indication into Non-Proliferative Diabetic Retinopathy (NPDR) and Proliferative Diabetic Retinopathy (PDR). NPDR is further sub segmented as Mild, Moderate and Severe.

Based on Treatment type the market is bifurcated into Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical Centers.

Non-proliferative retinopathy dominated the overall market size estimated to lead the market. Lack of diagnosis at right time, increased incidence of diabetes, and non-compliant retinal screening of diabetic patients are projected to propel the growth of non-proliferative diabetic retinopathy market share.

Enquire Now @ www.marketdataforecast.com/cart/bu…opathy-market-941

The Major companies in Diabetic Retinopathy treatment market are Bayer AG, Pfizer Inc., Hoffmann-La Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...